Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Johnson & Johnson Stock a Strong Buy?

TheMotleyFool

0 0

Is Johnson & Johnson Stock a Strong Buy?: https://g.foolcdn.com/editorial/images/738059/pills-dollar-symbol.jpg

Large-cap pharmaceuticals stocks that pay dividends frequently generate market-beating returns over the long term. The core reason is that these companies tend to sport healthy profit margins, sizable free cash flows, and modest competitive moats. Not all big pharma stocks are market slayers, however. For instance, healthcare behemoth Johnson & Johnson (NYSE: JNJ) hasn't outperformed the broader markets in six years.